Lunsotogene parvec, sold under the brand name Otarmeni, is a gene therapy treatment designed to reverse nonsyndromic deafness caused by a rare mutation in the OTOF gene.
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.